Role of Triggering Receptor Expressed on Myeloid Cells (TREM-1) as a Novel Biomarker in Human Epidermal Growth Factor Receptor -2 (HER-2) Negative Breast Cancer: a Molecular and Clinical Study
Not yet recruitingOBSERVATIONAL
Enrollment
1
Participants
Timeline
Start Date
September 15, 2025
Primary Completion Date
September 15, 2028
Study Completion Date
September 30, 2029
Conditions
Breast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage IIIBreast Cancer Invasive
Trial Locations (1)
71631
Assiut University Hospitals, Asyut
All Listed Sponsors
collaborator
Assiut University
OTHER
lead
Rahma Esam Salama Esawi
OTHER
NCT06950671 - Role of Triggering Receptor Expressed on Myeloid Cells (TREM-1) as a Novel Biomarker in Human Epidermal Growth Factor Receptor -2 (HER-2) Negative Breast Cancer: a Molecular and Clinical Study | Biotech Hunter | Biotech Hunter